Mangalam Drugs and Organics Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 57.35 | 73.25 | 88.84 |
| Operating Expense | 61.85 | 62.88 | 79.94 |
| Net Profit | -13.73 | 0.15 | 1.40 |
| Net Profit Margin | -23.94 | 0.20 | 1.58 |
| Earning Per Share | -8.67 | 0.10 | 0.89 |
| EBIDTA | -5.31 | 8.86 | 8.82 |
| Effective Tax Rate | TBA | 0.68 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 57.35 |
| Operating Expense | 61.85 |
| Net Profit | -13.73 |
| Net Profit Margin | -23.94 |
| Earning Per Share | -8.67 |
| EBIDTA | -5.31 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 318.23 | 368.59 | 372.25 |
| Operating Expenses Annual | 282.43 | 351.22 | 346.53 |
| Operating Profit Annual | 36.30 | 17.49 | 26.16 |
| Interest Annual | 14.93 | 13.92 | 12.96 |
| Depreciation | 16.38 | 14.63 | 10.99 |
| Net Profit Annual | 6.92 | -9.05 | 1.27 |
| Tax Annual | -1.93 | -2.01 | 0.94 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 318.23 |
| Operating Expenses Annual | 282.43 |
| Operating Profit Annual | 36.30 |
| Interest Annual | 14.93 |
| Depreciation | 16.38 |
| Net Profit Annual | 6.92 |
| Tax Annual | -1.93 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1 | 1.04 | 1.95 |
| Cash Flow from Operations | 42.76 | 12.17 | 38.08 |
| Cash Flow from Investing | -19.47 | -17.90 | -22.17 |
| Cash Flow from Financing | -21.71 | 5.70 | -16.82 |
| Cash Flow at the End | 2.57 | 1 | 1.04 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1 |
| Cash Flow from Operations | 42.76 |
| Cash Flow from Investing | -19.47 |
| Cash Flow from Financing | -21.71 |
| Cash Flow at the End | 2.57 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 11.41 | 4.75 | 7.03 |
| PBIT Margin (%) | 6.26 | 0.78 | 4.08 |
| PBT Margin (%) | 5.84 | 0.72 | 3.77 |
| Net PROFIT Margin (%) | 2.17 | -2.46 | 0.34 |
| Return On Networth / Equity (%) | 4.76 | -6.15 | 0.84 |
| Return On Networth /Employed (%) | 7.94 | 1.15 | 6.25 |
| Return On Assets (%) | 2.76 | -3.66 | 0.52 |
| Total Debt / Equity (X) | 0.70 | 0.66 | 0.58 |
| Asset Turnover Ratio (%) | 1.27 | 1.49 | 1.53 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 11.41 |
| PBIT Margin (%) | 6.26 |
| PBT Margin (%) | 5.84 |
| Net PROFIT Margin (%) | 2.17 |
| Return On Networth / Equity (%) | 4.76 |
| Return On Networth /Employed (%) | 7.94 |
| Return On Assets (%) | 2.76 |
| Total Debt / Equity (X) | 0.70 |
| Asset Turnover Ratio (%) | 1.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 158.21 | 155.04 | 151.85 |
| Total Current Assets Annual | 198.99 | 199.78 | 203.26 |
| Non Current Assets Annual | 160.25 | 157.36 | 154.72 |
| Total Shareholders Funds Annual | 148.66 | 142.35 | 151.96 |
| Total Assets Annual | 359.24 | 357.14 | 357.98 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 158.21 |
| Total Current Assets Annual | 198.99 |
| Non Current Assets Annual | 160.25 |
| Total Shareholders Funds Annual | 148.66 |
| Total Assets Annual | 359.24 |
EPS (INR)
Expected
0.00
Reported
-8.72
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
